These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30627429)

  • 1. Evaluation of carbapenem use in a tertiary hospital: antimicrobial stewardship urgently needed.
    Zhang D; Cui K; Lu W; Bai H; Zhai Y; Hu S; Li H; Dong H; Feng W; Dong Y
    Antimicrob Resist Infect Control; 2019; 8():5. PubMed ID: 30627429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.
    Abdallah M; Badawi M; Amirah MF; Rasheed A; Mady AF; Alodat M; Alharthy A
    J Antimicrob Chemother; 2017 Nov; 72(11):3187-3190. PubMed ID: 28961733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.
    Peña C; Suarez C; Gozalo M; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez F; Tubau F; Martínez-Martínez L; Oliver A;
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1265-72. PubMed ID: 22155832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa.
    Pakyz AL; Oinonen M; Polk RE
    Antimicrob Agents Chemother; 2009 May; 53(5):1983-6. PubMed ID: 19273670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
    Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
    J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
    Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
    J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
    Chen Z; Xu Z; Wu H; Chen L; Gao S; Chen Y
    Am J Infect Control; 2019 Jun; 47(6):677-682. PubMed ID: 30554879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant
    Huang W; Wei X; Xu G; Zhang X; Wang X
    Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of the Antimicrobial Stewardship Team Intervention Focusing on Changes in Prescribing Trends and the Rate of Carbapenem-resistant P. aeruginosa].
    Naito Y; Maeda M; Nagatomo Y; Ugajin K; Akima E; Tanaka M; Tokimatsu I; Sasaki T
    Yakugaku Zasshi; 2022; 142(5):527-534. PubMed ID: 35491159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate and later impacts of antimicrobial consumption on carbapenem-resistant Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. in a teaching hospital in Brazil: a 10-year trend study.
    Federico MP; Furtado GH
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2153-2158. PubMed ID: 30112695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation.
    Asuphon O; Montakantikul P; Houngsaitong J; Kiratisin P; Sonthisombat P
    Int J Infect Dis; 2016 Sep; 50():23-9. PubMed ID: 27418581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Carbapenem Selection on Drug Acquisition Costs and Carbapenem Resistance.
    Smoke SM; Abdul W; Grigoriu A; Vasant D
    J Pharm Pract; 2019 Feb; 32(1):7-8. PubMed ID: 29587577
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
    Lin KY; Lauderdale TL; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of carbapenem-resistance
    Wei J; Zhu QL; Sun Z; Wang C
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):353-359. PubMed ID: 32370463
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.